hrotha said:
This is where his explanation breaks down. The fact that there wasn't a positive for EPO is irrelevant, and therefore #1 can easily be explained by microdosing.
CAS will have a very easy task if this is what Kreuziger has.
Either way, as has been mentioned previously, CAS decision on this will serve as a crucial indicator of UCI ability to use ABP as a basis for chasing future (and past) dopers, especially in such more subtle cases in which threshold values were not exceeded.
But then if CAS upholds UCI's claims, why don't we see more of this? Are we supposed to believe that there were no more blood bags taken by other riders in Grand Tours? Or were the others just lucky they were not tested on the right (wrong) days? If it would make sense to test every relevant rider towards the end of the GT to check the Hgb/Hct trend - is this done? If yes (GC leaders probably are tested) and if similar suspicious patterns are not observed, I would be much relieved, at least that blood bags are no more used during the GTs.
There's also another question I can not answer to myself: Did Kreuziger have any incentive to take blood bag at that Giro moment? Both yes and no.
Yes, because he needed to improve his reputation by winning at least the stage. And because Vinokourov was at the finish and
welcomed the performance of his teammate. "This is the response of a true champion,".
On the other hand, the GC battle was over for him. Would he really take the risk of being caught just to earn the stage win? Especially if Astana DS Martinelli said a few days before:
"We didn't bring Kreuziger for a stage win. We brought him for the podium. We got the stage win we wanted with Paolo Tiralongo."
quotes are from
http://www.cyclingnews.com/news/kreuziger-not-consoled-by-giro-stage-win